Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Polyvalent vaccine approaches to combat HIV‐1 diversity
Bette Korber, Peter Hraber, Kshitij Wagh, et al.
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 230-244
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Self-amplifying RNA vaccines for infectious diseases
Kristie Bloom, Fiona T. van den Berg, Patrick Arbuthnot
Gene Therapy (2020) Vol. 28, Iss. 3-4, pp. 117-129
Open Access | Times Cited: 340
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Barton F. Haynes, Kevin Wiehe, Persephone Borrow, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 142-158
Open Access | Times Cited: 217
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
Christine A. Bricault, Karina Yusim, Michael S. Seaman, et al.
Cell Host & Microbe (2019) Vol. 25, Iss. 1, pp. 59-72.e8
Open Access | Times Cited: 160
The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication
Qin Ning, Di Wu, Xiaojing Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 70
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence
Kwinten Sliepen, Byung Woo Han, Ilja Bontjer, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 138
Completeness of HIV-1 Envelope Glycan Shield at Transmission Determines Neutralization Breadth
Kshitij Wagh, Edward F. Kreider, Yingying Li, et al.
Cell Reports (2018) Vol. 25, Iss. 4, pp. 893-908.e7
Open Access | Times Cited: 106
Vaccines and Broadly Neutralizing Antibodies for HIV-1 Prevention
Kathryn E. Stephenson, Kshitij Wagh, Bette Korber, et al.
Annual Review of Immunology (2020) Vol. 38, Iss. 1, pp. 673-703
Open Access | Times Cited: 102
The quest for an antibody-based HIV vaccine
Barton F. Haynes, John R. Mascola
Immunological Reviews (2017) Vol. 275, Iss. 1, pp. 5-10
Open Access | Times Cited: 96
HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
Will Fischer, Elena E. Giorgi, Srirupa Chakraborty, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1093-1110
Open Access | Times Cited: 90
cGMP production and analysis of BG505 SOSIP.664, an extensively glycosylated, trimeric HIV‐1 envelope glycoprotein vaccine candidate
Antu Dey, Albert Cupo, Gabriel Ozorowski, et al.
Biotechnology and Bioengineering (2017) Vol. 115, Iss. 4, pp. 885-899
Open Access | Times Cited: 79
Nanoparticle vaccines against viral infections
Fernando Bandeira Sulczewski, Raquel Bester Liszbinski, Pedro Roosevelt Torres Romão, et al.
Archives of Virology (2018) Vol. 163, Iss. 9, pp. 2313-2325
Closed Access | Times Cited: 47
FOXP3 as a prognostic marker and therapeutic target in immunogenic cell death modulation for clear cell renal cell carcinoma
Jian Chen, Cheng Zhu, Yan He, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Phylogenetic patterns recover known HIV epidemiological relationships and reveal common transmission of multiple variants
Thomas Leitner, Ethan Romero-Severson
Nature Microbiology (2018) Vol. 3, Iss. 9, pp. 983-988
Open Access | Times Cited: 45
Experimental medicine study with stabilised native-like HIV-1 Env immunogens drives long-term antibody responses, but lacks neutralising breadth
Katrina M. Pollock, Hannah M. Cheeseman, Leon R. McFarlane, et al.
EBioMedicine (2025) Vol. 112, pp. 105544-105544
Open Access
Exploitation of Unconventional CD8 T-Cell Responses Induced by Engineered Cytomegaloviruses for the Development of an HIV-1 Vaccine
Joseph Bruton, Tomáš Hanke
Vaccines (2025) Vol. 13, Iss. 1, pp. 72-72
Open Access
A polyvalent DNA prime with matched polyvalent protein/GLA-SE boost regimen elicited the most robust and broad IgG and IgG3 V1V2 binding antibody and CD4+ T cell responses among 13 HIV vaccine trials
Zoe Moodie, Shuying Sue Li, Elena E. Giorgi, et al.
Emerging Microbes & Infections (2025) Vol. 14, Iss. 1
Open Access
Nano-based approaches in the development of antiviral agents and vaccines
Yang Li, Yushuo Xiao, Yuchen Chen, et al.
Life Sciences (2020) Vol. 265, pp. 118761-118761
Open Access | Times Cited: 29
HIV-1 genetic diversity a challenge for AIDS vaccine development: a retrospective bibliometric analysis
Abdur Rashid, Kang Li, Yi Feng, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 18
Clinical trials and recent progress in HIV vaccine development
Akmal Zubair, Bushra Bibi, Faiza Habib, et al.
Functional & Integrative Genomics (2024) Vol. 24, Iss. 5
Closed Access | Times Cited: 3
Conserved HIV Epitopes for an Effective HIV Vaccine
Bikash Sahay, Cuong Q. Nguyen, Janet K. Yamamoto
Journal of Clinical & Cellular Immunology (2017) Vol. 08, Iss. 04
Open Access | Times Cited: 29
Hitting the sweet spot: exploiting HIV-1 glycan shield for induction of broadly neutralizing antibodies
Kshitij Wagh, Beatrice H. Hahn, Bette Korber
Current Opinion in HIV and AIDS (2020) Vol. 15, Iss. 5, pp. 267-274
Open Access | Times Cited: 27
Global and Regional Estimates for Subtype-Specific Therapeutic and Prophylactic HIV-1 Vaccines: A Modeling Study
Ramyiadarsini Elangovan, Michael Jenks, Jason Yun, et al.
Frontiers in Microbiology (2021) Vol. 12
Open Access | Times Cited: 22
Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Kristen W. Cohen, Andrew Fioré-Gartland, Stephen R. Walsh, et al.
Journal of Clinical Investigation (2023) Vol. 133, Iss. 4
Open Access | Times Cited: 8
Models of immune selection for multi-locus antigenic diversity of pathogens
Maria Georgieva, Caroline O. Buckee, Marc Lipsitch
Nature reviews. Immunology (2018) Vol. 19, Iss. 1, pp. 55-62
Open Access | Times Cited: 27
Chronic schistosomiasis suppresses HIV-specific responses to DNA-MVA and MVA-gp140 Env vaccine regimens despite antihelminthic treatment and increases helminth-associated pathology in a mouse model
Godfrey Dzhivhuho, Samantha A. Rehrl, Hlumani Ndlovu, et al.
PLoS Pathogens (2018) Vol. 14, Iss. 7, pp. e1007182-e1007182
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top